摘要
目的:研究蛋白酶激活受体的激活在凝血酶所致大鼠脑损伤中的作用,以及与神经细胞再生的关系。方法:90只成年雄性SD大鼠随机分为5组,分别海马注射生理盐水(NS)、凝血酶以及3种蛋白酶激活受体的特异性激动剂,注射1 d、3 d、7 d后,用HE染色检测海马面积变化,用胶质纤维酸性蛋白(GFAP)染色检测星形胶质细胞数量和形态,用Flouro-Jade C染色检测神经元变性,微管相关蛋白(DCX)标记检测神经细胞再生。结果:与NS组比较,注射凝血酶和蛋白酶激活受体-1激动剂后1~3 d出现海马面积显著增大(P<0.05),7 d出现海马面积明显缩小;注射后1~7 d GFAP阳性细胞、Flouro-Jade C阳性细胞增多(P<0.05);注射后3~7 d DCX阳性细胞增多(P<0.05)。而注射蛋白酶激活受体-3激动剂和蛋白酶激活受体-4激动剂均未见上述变化。结论:蛋白酶激活受体-1激活可能参与凝血酶所致的急性期脑损伤以及后期的神经再生。
Objective: To investigate the roles of protease-activated receptors(PARs) in thrombin-induced brain injury and neurogenesis in rats.Methods: Ninety male SD rats were randomly assigned to receive intra-hippocampus injection of NS,thrombin or specific agonists of 3 protease-activated receptors(PAR-1,PAR-3 and PAR-4),respectively.At 1,3 and 7 d after injection,the area of the hippocampus was determined with HE staining,the density and morphology of astrocyte were detected with GFAP staining,degenerated neurons were detected with Flouro-Jade C staining,and the neurogenesis was examined with DCX staining.Results: Compared to NS injection,the area of the hippocampus significantly increased at 1-3 d and decreased at 7 d after the injection of thrombin and PAR-1 agonist(P0.05).In addition,injection of thrombin and PAR-1 agonist significantly increased the density of astrocyte and Flouro-Jade C positive cells at 1-7 d after injection(P0.05),and significantly increased the density of DCX positive cells at 3-7 d after injection(P0.05).The injection of PAR-3 agonist and PAR-4 agonist had no affect on the area of the hippocampus,the density of astrocyte,Flouro-Jade C positive cells and DCX positive cells.Conclusion: The activation of protease-activated receptor-1 may be related to the thrombin-induced brain injury and neurogenesis in rat hippocampus.
出处
《浙江大学学报(医学版)》
CAS
CSCD
北大核心
2013年第3期283-290,共8页
Journal of Zhejiang University(Medical Sciences)
基金
浙江省钱江人才计划基金(2009R10019)
国家自然科学基金(81100909)
教育部博士点新教师基金(20100101120133)
关键词
脑出血
病理学
凝血酶
药理学
受体
蛋白酶激活
拮抗剂和抑制剂
神经再生
药物作用
随机对照试验
Cerebral hemorrhage/pathology
Thrombin/pharmacology
Receptors
proteinase-activated/antagonists & inhibitors
Nerve regeneration/drug effects
Randomized controlled trial